Trial Profile
Pilot Trial of Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft Versus Host Disease Following Unrelated Donor Allogeneic Transplant
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary) ; Methotrexate; Tacrolimus
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 13 Jul 2018 Status changed from active, no longer recruiting to completed.
- 07 Aug 2017 Results published in the Blood
- 10 Jul 2017 New trial record